0.00Open0.26Pre Close0 Volume75 Open Interest17.50Strike Price0.00Turnover55.93%IV15.32%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.26Extrinsic Value100Contract SizeAmericanOptions Type0.2181Delta0.1321Gamma59.23Leverage Ratio-0.0139Theta0.0021Rho12.92Eff Leverage0.0117Vega
KalVista Pharmaceuticals Stock Discussion
$Regenxbio(RGNX.US)$ Phase 3
$Annovis Bio(ANVS.US)$ Phase 3
$Atea Pharmaceuticals(AVIR.US)$ Phase 3
$Ironwood Pharmaceuticals(IRWD.US)$ Phase 3
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 3
$Vertex Pharmaceuticals(VRTX.US)$ Phase 3
$KalVista Pharmaceuticals(KALV.US)$ Phase 3
$Axsome Therapeutics(AXSM.US)$ Phase 3
$Novocure(NVCR.US)$ Phase 3
$ROCHE HOLDING AG(RHHBY.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$Applied Therapeutics(APLT.US)$ Phase 3
$ACADIA Pharmaceuticals(ACAD.US)$ Phase 3 ...
No comment yet